Overall rank by patents
#1,709
Across all tracked assignees
USPTO PatentsView assignee record - 239 granted patents across 46 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
Medtronic holds 239 US patents across 46 technology areas, rank #1,709 of 50,000 tracked assignees.
Medtronic Xomed, Inc. has been granted 239 US utility patents between 2015 and 2025, placing Medtronic Xomed, Inc. at rank #1,709 across all assignees tracked by PlainPatent. This portfolio spans 46 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.6 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Medtronic Xomed, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Medtronic sits between Southwire Company, Llc (241 patents, rank #1,705) and ZKW Group Gmbh (239 patents, rank #1,713) - the closest US assignees by grant volume. The composite Innovation Score of 61.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 137 grants, compared with 102 in the 2015–2019 window, a +34% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Medtronic Xomed, Inc.'s 17.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 46 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Medtronic Xomed, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Southwire Company, LLC
241 patents
ARKRAY, Inc.
240 patents
DANA HEAVY VEHICLE SYSTEMS GROUP, LLC
240 patents
ENTIT SOFTWARE LLC
239 patents
NIKKISO CO., LTD.
239 patents
Theravance Biopharma R&D IP, LLC
239 patents
VORWERK & CO. INTERHOLDING GMBH
239 patents
ZKW Group GmbH
239 patents
Medtronic Xomed, Inc.
239 patents
What this shows Medtronic holds 239 patents at rank #1,709, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #1,709 in granted patent volume.
Other assignees with the most granted patents in Medtronic's primary technology class.
Medtronic's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
62 Top 3% higher than 97% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 18 | 7.5% |
| 2016 | 20 | 8.4% |
| 2017 | 18 | 7.5% |
| 2018 | 20 | 8.4% |
| 2019 | 26 | 10.9% |
| 2020 | 18 | 7.5% |
| 2021 | 22 | 9.2% |
| 2022 | 18 | 7.5% |
| 2023 | 28 | 11.7% |
| 2024 | 38 | 15.9% |
| 2025 | 13 | 5.4% |
Top 15 of 46 technology areas
Overall rank by patents
#1,709
Across all tracked assignees
61.9 out of 100
How to use this portfolio
Medtronic's 239 grants land it in the top 3% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.